Peter Soparkar, CHIEF OPERATING OFFICER at Adverum Biotechnologies, Inc. (ADVM), sold 2,960 shares at $2.00 ($6K) on 2025-05-15, disclosed to the SEC on 2025-05-16.
Open-market sale of $6k ADVM by CHIEF OPERATING OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ADVM | SELL | 2022-09-21 | $14K | — | Filing → |
| ADVM | BUY | 2022-04-20 | $25K | — | Filing → |
| ADVM | BUY | 2021-12-10 | $48K | — | Filing → |